Prudential Downgrades NPS Pharmaceuticals

Analyst Jason Zhang believes that without a marketing partner for its Preos drug, he doesn't see any catalysts to drive the pharma stock higher in 2005

Prudential downgrades NPS Pharmaceuticals (NPSP ) to neutral from overweight.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.